CIZ | CVIE | CIZ / CVIE | |
Gain YTD | 9.282 | 6.184 | 150% |
Net Assets | 24M | 112M | 21% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 320.00 | 13.00 | 2,462% |
Yield | 3.23 | 1.90 | 169% |
Fund Existence | 10 years | 2 years | - |
CIZ | CVIE | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 26 days ago75% | 3 days ago89% |
Momentum ODDS (%) | N/A | 3 days ago78% |
MACD ODDS (%) | N/A | N/A |
TrendWeek ODDS (%) | 26 days ago69% | 3 days ago75% |
TrendMonth ODDS (%) | 26 days ago68% | 3 days ago58% |
Advances ODDS (%) | N/A | 13 days ago79% |
Declines ODDS (%) | N/A | 5 days ago75% |
BollingerBands ODDS (%) | 26 days ago82% | 3 days ago90% |
Aroon ODDS (%) | N/A | 3 days ago50% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EMRGX | 6.82 | -0.03 | -0.44% |
Emerging Markets Growth Fund M | |||
ICPUX | 5.99 | -0.03 | -0.50% |
Integrity Mid-North American Resources C | |||
FZILX | 11.73 | -0.06 | -0.51% |
Fidelity ZERO International Index | |||
MSCLX | 19.31 | -0.26 | -1.33% |
MassMutual Small Cap Opps Adm | |||
PHPIX | 26.83 | -1.12 | -4.01% |
ProFunds Pharmaceuticals UltraSector Inv |
A.I.dvisor indicates that over the last year, CIZ has been loosely correlated with BAM. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CIZ jumps, then BAM could also see price increases.
A.I.dvisor indicates that over the last year, CVIE has been loosely correlated with BAM. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CVIE jumps, then BAM could also see price increases.
Ticker / NAME | Correlation To CVIE | 1D Price Change % | ||
---|---|---|---|---|
CVIE | 100% | -0.36% | ||
BAM - CVIE | 62% Loosely correlated | -0.54% | ||
BN - CVIE | 56% Loosely correlated | -1.75% | ||
JHG - CVIE | 54% Loosely correlated | -2.54% | ||
SLF - CVIE | 54% Loosely correlated | -1.34% | ||
MFC - CVIE | 54% Loosely correlated | -0.64% | ||
More |